HomeCompareAKBLF vs ADC

AKBLF vs ADC: Dividend Comparison 2026

AKBLF yields 0.80% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADC wins by $158.1K in total portfolio value
10 years
AKBLF
AKBLF
● Live price
0.80%
Share price
$31.35
Annual div
$0.25
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.8K
Annual income
$83.98
Full AKBLF calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — AKBLF vs ADC

📍 ADC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAKBLFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AKBLF + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AKBLF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AKBLF
Annual income on $10K today (after 15% tax)
$67.78/yr
After 10yr DRIP, annual income (after tax)
$71.38/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, ADC beats the other by $68,606.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AKBLF + ADC for your $10,000?

AKBLF: 50%ADC: 50%
100% ADC50/50100% AKBLF
Portfolio after 10yr
$99.9K
Annual income
$40,440.64/yr
Blended yield
40.49%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

AKBLF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
11.6
Piotroski
8/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AKBLF buys
0
ADC buys
0
No recent congressional trades found for AKBLF or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAKBLFADC
Forward yield0.80%4.13%
Annual dividend / share$0.25$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$20.8K$178.9K
Annual income after 10y$83.98$80,797.29
Total dividends collected$820.00$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: AKBLF vs ADC ($10,000, DRIP)

YearAKBLF PortfolioAKBLF Income/yrADC PortfolioADC Income/yrGap
1← crossover$10,780$79.74$10,990$580.36$210.00ADC
2$11,615$80.34$12,301$860.26$686.00ADC
3$12,509$80.90$14,104$1,298.62$1.6KADC
4$13,466$81.43$16,691$2,008.16$3.2KADC
5$14,490$81.92$20,580$3,205.09$6.1KADC
6$15,587$82.39$26,754$5,330.02$11.2KADC
7$16,761$82.82$37,196$9,345.14$20.4KADC
8$18,017$83.24$56,244$17,523.09$38.2KADC
9$19,362$83.62$94,286$35,736.21$74.9KADC
10$20,801$83.98$178,949$80,797.29$158.1KADC

AKBLF vs ADC: Complete Analysis 2026

AKBLFStock

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.

Full AKBLF Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this AKBLF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AKBLF vs SCHDAKBLF vs JEPIAKBLF vs OAKBLF vs KOAKBLF vs MAINAKBLF vs NNNAKBLF vs EPRTAKBLF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.